Skip to main content
. 2024 Dec 11;9(51):50695–50704. doi: 10.1021/acsomega.4c08627

Table 1. Antibacterial Activity of 38 Compounds against Xoo, Rs, and Aac.

      inhibition rate (%)
compound n R Xoo Rs Aac
A1 3 H 76.05 35.57 60.21
A2 4 H 78.18 34.43 54.78
A3 3 2-OCH3 18.89 39.60 17.51
A4 4 2-OCH3 1.36 40.87 14.62
A5 3 2-CH3 9.50 8.10 25.38
A6 4 2-CH3 22.38 18.60 19.05
A7 3 2-Br 44.2 30.93 67.22
A8 4 2-Br 39.03 22.6 54.1
A9 3 2-Cl 90.68 44.62 93.71
A10 4 2-Cl 76.64 35.8 71.32
A11 3 2-F 64.76 26.66 63.35
A12 4 2-F 58.12 40.05 61.14
A13 3 2,4-di-Cl 89.29 27.31 84.1
A14 4 2,4-di-Cl 65.47 18.89 2.72
A15 3 3,5-di-Cl 25.49 7.60 17.90
A16 4 3-OCH3 30.75 40.3 69.37
A17 3 3-CH3 42.62 37.28 67.26
A18 4 3-CH3 38.26 36.05 46.91
A19 4 3,5-di-Cl 32.92 22.96 22.25
A20 4 3-Br 18.43 20.29 3.29
A21 3 3-Cl 47.88 33.72 20.25
A22 4 3-Cl 35.75 23.14 2.05
A23 3 3-F 73.30 15.00 18.99
A24 4 3-F 25.10 13.28 26.94
A25 3 3-CF3 79.13 16.60 20.89
A26 4 3-CF3 51.04 10.37 8.37
A27 3 4-OCH3 72.87 42.29 47.65
A28 4 4-OCH3 64.23 21.65 4.72
A29 3 4-CH3 66.37 40.02 69.58
A30 4 4-CH3 71.24 42.51 65.87
A31 3 4-Br 55.69 22.70 14.11
A32 4 4-Br 45.80 27.12 11.30
A33 3 4-Cl 72.51 24.52 53.86
A34 4 4-Cl 70.83 26.35 61.56
A35 3 4-F 82.76 34.76 72.87
A36 4 4-F 69.08 34.85 63.93
A37 3 4-CF3 71.43 21.75 33.12
A38 4 4-CF3 79.04 34.31 57.46
3-CCA     64.92 51.24 56.44
kasugamycin     90.14 78.3 95.24